Cartesian Therapeutics(RNAC)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RNAC Cartesian Therapeutics

休市中 05-03 16:00:00 EDT

25.60

+1.17

+4.79%

盘后25.60

+0.000.00%

17:59 EDT

最高27.29	最低24.78	成交量13.74万
今开26.24	昨收24.43	日振幅10.29%
总市值4.55亿	流通市值9,118万	总股本1,778万
成交额356.82万	换手率3.86%	流通股本356.16万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RNAC","market":"US","secType":"STK","nameCN":"Cartesian Therapeutics","latestPrice":25.6,"timestamp":1714766400000,"preClose":24.43,"halted":0,"volume":137405,"hourTrading":{"tag":"盘后","latestPrice":25.6,"preClose":25.6,"latestTime":"17:59 EDT","volume":28,"amount":696.3798,"timestamp":1714773546713},"delay":0,"floatShares":3561625,"shares":17779787,"eps":-49.8001,"marketStatus":"休市中","marketStatusCode":7,"change":1.17,"latestTime":"05-03 16:00:00 EDT","open":26.24,"high":27.29,"low":24.7766,"amount":3568199.4066149998,"amplitude":0.102882,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-49.8001,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"adr":0,"listingDate":1466568000000,"adjPreClose":24.43,"preHourTrading":{"tag":"盘前","latestPrice":25.45,"preClose":24.43,"latestTime":"09:29 EDT","volume":82,"amount":2086.59004,"timestamp":1714742969067},"postHourTrading":{"tag":"盘后","latestPrice":25.6,"preClose":25.6,"latestTime":"17:59 EDT","volume":28,"amount":696.3798,"timestamp":1714773546713},"volumeRatio":1.196828431084448},"requestUrl":"/m/hq/s/RNAC","defaultTab":"news","newsList":[{"id":"2431032992","title":"Cartesian Therapeutics Inc    预计每股亏损 88 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431032992","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431032992?lang=zh_cn&edition=full","pubTime":"2024-04-30 21:55","pubTimestamp":1714485311,"startTime":"0","endTime":"0","summary":"   * Cartesian Therapeutics Inc    预计将在5月2日公布截至0001年1月1日的业绩报告(估计)，季度收入将出现下降。* 根据LSEG的数据，4位分析师的平均预期显示，这家总部位于马萨诸塞州沃特敦的公司的营收预计将从去年同期的594万美元下降78.9%，至125万美元。* LSEG 分析师对 Cartesian Therapeutics Inc 的平均预期是每股亏损 88 美分。* 华尔街对 Cartesian Therapeutics Inc 的 12 个月目标价中位数为 42.00 美元，高于其上次收盘价 22.00 美元。4月30日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417761127","title":"Cartesian Therapeutics Inc 报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2417761127","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417761127?lang=zh_cn&edition=full","pubTime":"2024-03-07 22:02","pubTimestamp":1709820177,"startTime":"0","endTime":"0","summary":"   * Cartesian Therapeutics Inc   报告，截至12月底的季度调整后每股亏损7美分，低于去年同期的每股收益4美分。华尔街预期为每股-5美分至-2美分。* 营收同比下降 50.8%，至 827 万美元；分析师预期为 588 万美元。* Cartesian Therapeutics Inc 公布的本季度每股收益为亏损 1.39 美元。* 该公司一季度亏损 1.7766 亿美元。* Cartesian Therapeutics Inc 的股价本季度上涨了 1.5%。华尔街对 Cartesian Therapeutics Inc 的 12 个月目标价中位数为 2.50 美元。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417176870","title":"美国研究综述-CommScope Holding Company、Dutch Bros、Hess","url":"https://stock-news.laohu8.com/highlight/detail?id=2417176870","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417176870?lang=zh_cn&edition=full","pubTime":"2024-03-05 03:21","pubTimestamp":1709580103,"startTime":"0","endTime":"0","summary":"    路透社3月4日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括 CommScope Holding Company、Dutch Bros 和 Hess。要点 * CommScope Holding Company   ：摩根大通将其股票评级从中性下调至减持  * 荷兰兄弟  ：Piper Sandler 将其评级从中性上调至增持  * Hess Corp   ：Susquehanna 将目标价从 152 美元上调至 156 美元  * Pioneer Natural Resources Co   ：苏斯克汉纳将目标价从237美元上调至246美元  * United Therapeutics Corp   ：摩根大通将目标价从294美元下调至280美元  以下是路透社周一报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414804970","title":"Cartesian Therapeutics Inc    预计每股亏损 4 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2414804970","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414804970?lang=zh_cn&edition=full","pubTime":"2024-02-28 00:05","pubTimestamp":1709049949,"startTime":"0","endTime":"0","summary":"   * Cartesian Therapeutics Inc    预计将在2月29日公布截至2023年12月31日的业绩报告时显示季度收入下降(估计)。* 根据LSEG的数据，2位分析师的平均预期显示，这家总部位于马萨诸塞州沃特敦的公司的营收预计将从去年同期的1680万美元下降65.0%，至587.5万美元。* LSEG 分析师对 Cartesian Therapeutics Inc 的平均预期是每股亏损 4 美分。* 华尔街对 Cartesian Therapeutics Inc 的 12 个月目标价中位数为 3.50 美元，高于其上一次收盘价 0.75 美元。2月27日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2383036263","title":"Selecta Biosciences Inc盘中异动 早盘股价大跌12.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2383036263","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2383036263?lang=zh_cn&edition=full","pubTime":"2023-11-13 22:32","pubTimestamp":1699885968,"startTime":"0","endTime":"0","summary":"北京时间2023年11月13日22时32分，Selecta Biosciences Inc股票出现异动，股价快速下挫12.31%。Selecta Biosciences Inc股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，Tenax Therapeutics Inc、Engene Holdings Inc C/Wts 31/10/2028  Cl A、Zyversa Therapeutics Inc涨幅较大，Tenax Therapeutics Inc、Zyversa Therapeutics Inc、Paxmedica Inc较为活跃，换手率分别为102.94%、64.95%、8.26%，振幅较大的相关个股有Tenax Therapeutics Inc、Xortx Therapeutics Inc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为28.08%、24.68%、16.67%。Selecta Biosciences Inc公司简介：Selecta Biosciences Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231113223248840fe51b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231113223248840fe51b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2382737969","title":"Selecta Biosciences Inc盘中异动 临近午盘急速下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2382737969","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2382737969?lang=zh_cn&edition=full","pubTime":"2023-11-11 00:39","pubTimestamp":1699634368,"startTime":"0","endTime":"0","summary":"北京时间2023年11月11日00时39分，Selecta Biosciences Inc股票出现波动，股价急速跳水5.00%。截至发稿，该股报0.950美元/股，成交量35.5809万股，换手率0.23%，振幅5.58%。Selecta Biosciences Inc股票所在的生物技术行业中，整体跌幅为0.70%。Selecta Biosciences Inc公司简介：Selecta Biosciences Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231111003929839bb407&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231111003929839bb407&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2382223528","title":"Selecta Biosciences Inc盘中异动 急速下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2382223528","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2382223528?lang=zh_cn&edition=full","pubTime":"2023-11-10 04:50","pubTimestamp":1699563015,"startTime":"0","endTime":"0","summary":"北京时间2023年11月10日04时50分，Selecta Biosciences Inc股票出现波动，股价急速下挫5.14%。Selecta Biosciences Inc股票所在的生物技术行业中，整体跌幅为2.44%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Ys Biopharma Co Ltd C/Wts 15/03/2028 、Lantern Pharma Inc涨幅较大，Tempest Therapeutics Inc、Paxmedica Inc、Cardio Diagnostics Holdings Inc较为活跃，换手率分别为289.55%、102.01%、91.48%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Engene Holdings Inc C/Wts 31/10/2028  Cl A，振幅分别为309.41%、99.17%、72.95%。Selecta Biosciences Inc公司简介：Selecta Biosciences Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231110045015847612a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231110045015847612a3&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.selectabio.com","stockEarnings":[{"period":"1week","weight":0.2173},{"period":"1month","weight":0.7411},{"period":"3month","weight":0.2056},{"period":"6month","weight":-0.258},{"period":"1year","weight":-0.2025},{"period":"ytd","weight":0.2378}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cartesian Therapeutics, Inc.在特拉华州成立。该公司是一家临床阶段的公司，开创了治疗自身免疫性疾病的RNA细胞疗法。该公司的主要资产Descartes-08是一种潜在的first-in-class、RNA工程嵌合抗原受体T细胞疗法（rCAR-T），正处于全身性重症肌无力患者的2b期临床开发阶段，并计划在系统性红斑狼疮以及眼部自身免疫和血管性自身免疫篮子试验中开展额外的2期研究。Cartesian在马里兰州盖瑟斯堡经营一家全资拥有的最先进的cGMP生产设施。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.068578},{"month":2,"riseRate":0.625,"avgChangeRate":0.005872},{"month":3,"riseRate":0.5,"avgChangeRate":-0.065102},{"month":4,"riseRate":0.375,"avgChangeRate":-0.088284},{"month":5,"riseRate":0.75,"avgChangeRate":0.148744},{"month":6,"riseRate":0.428571,"avgChangeRate":0.089891},{"month":7,"riseRate":0.25,"avgChangeRate":-0.073014},{"month":8,"riseRate":0.875,"avgChangeRate":0.113315},{"month":9,"riseRate":0.375,"avgChangeRate":-0.001835},{"month":10,"riseRate":0.5,"avgChangeRate":-0.028704},{"month":11,"riseRate":0.625,"avgChangeRate":-0.020851},{"month":12,"riseRate":0.25,"avgChangeRate":-0.123636}],"exchange":"NASDAQ","name":"Cartesian Therapeutics","nameEN":"Cartesian Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cartesian Therapeutics(RNAC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cartesian Therapeutics(RNAC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cartesian Therapeutics,RNAC,Cartesian Therapeutics股票,Cartesian Therapeutics股票老虎,Cartesian Therapeutics股票老虎国际,Cartesian Therapeutics行情,Cartesian Therapeutics股票行情,Cartesian Therapeutics股价,Cartesian Therapeutics股市,Cartesian Therapeutics股票价格,Cartesian Therapeutics股票交易,Cartesian Therapeutics股票购买,Cartesian Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cartesian Therapeutics(RNAC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cartesian Therapeutics(RNAC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况